Cargando…

Clinical Utility of Increased Nuchal Translucency at 11–13 Weeks of Gestation in Twin Pregnancies Based on the Chorionicity

To assess clinical implications of increased nuchal translucency (INT) in twin pregnancies based on the chorionicity. This was a retrospective review of the twin pregnancies who underwent first trimester ultrasound with nuchal translucency (NT) measurement at 11–13 weeks of gestation from January 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, SiWon, Lee, Hyun-Mi, Han, You Jung, Kim, Moon Young, Boo, Hye Yeon, Chung, Jin Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865212/
https://www.ncbi.nlm.nih.gov/pubmed/33498637
http://dx.doi.org/10.3390/jcm10030433
_version_ 1783647793031675904
author Lee, SiWon
Lee, Hyun-Mi
Han, You Jung
Kim, Moon Young
Boo, Hye Yeon
Chung, Jin Hoon
author_facet Lee, SiWon
Lee, Hyun-Mi
Han, You Jung
Kim, Moon Young
Boo, Hye Yeon
Chung, Jin Hoon
author_sort Lee, SiWon
collection PubMed
description To assess clinical implications of increased nuchal translucency (INT) in twin pregnancies based on the chorionicity. This was a retrospective review of the twin pregnancies who underwent first trimester ultrasound with nuchal translucency (NT) measurement at 11–13 weeks of gestation from January 2006 to December 2014. Data were collected using the OB database and the chart review. Pregnancy outcomes, including gestational weeks at the delivery, abnormal fetal karyotypes, fetal structural anomalies, and twin-specific complications, were analyzed. A total of 1622 twin pregnancies with INT ≥ 95th percentile in one or both fetuses were identified. In all twin pregnancies with INT, abnormal fetal karyotypes were identified in 17 (8.6%) patients (odds ratio = 13.28, CI = 5.990–29.447, p = 0.000) and twin-specific complications were identified in 23 (11.6%) patients (odds ratio = 2.398, CI = 1.463–3.928, p = 0.001) compared to those with normal NT. Among the INT group, when the groups were subdivided into monochorionic (MC) and dichorionic (DC) pregnancies, 14.8% and 29.6% of the MC pregnancies had structural anomalies in one or both fetuses (odds ratio = 5.774, 95% CI = 1.445–23.071, p = 0.01) and twin-specific complications (odds ratio = 4.379, 95% CI = 1.641–11.684, p = 0.03), respectively, compared to DC pregnancies with 2.9% for structural anomalies and 8.8% for twin-specific complications. The prevalence of abnormal fetal karyotypes was not statistically different in patients with INT when compared between MC and DC pregnancies (p = 0.329). INT was associated with a higher rate of twin-specific complications and fetal structural anomalies in MC twin pregnancies rather than abnormal fetal karyotype. Therefore, NT measurement in MC twin pregnancies can be a useful tool for predicting adverse pregnancy outcomes. Appropriate counseling and surveillance based on the chorionicity are imperative in the prenatal care of twin pregnancies.
format Online
Article
Text
id pubmed-7865212
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78652122021-02-07 Clinical Utility of Increased Nuchal Translucency at 11–13 Weeks of Gestation in Twin Pregnancies Based on the Chorionicity Lee, SiWon Lee, Hyun-Mi Han, You Jung Kim, Moon Young Boo, Hye Yeon Chung, Jin Hoon J Clin Med Article To assess clinical implications of increased nuchal translucency (INT) in twin pregnancies based on the chorionicity. This was a retrospective review of the twin pregnancies who underwent first trimester ultrasound with nuchal translucency (NT) measurement at 11–13 weeks of gestation from January 2006 to December 2014. Data were collected using the OB database and the chart review. Pregnancy outcomes, including gestational weeks at the delivery, abnormal fetal karyotypes, fetal structural anomalies, and twin-specific complications, were analyzed. A total of 1622 twin pregnancies with INT ≥ 95th percentile in one or both fetuses were identified. In all twin pregnancies with INT, abnormal fetal karyotypes were identified in 17 (8.6%) patients (odds ratio = 13.28, CI = 5.990–29.447, p = 0.000) and twin-specific complications were identified in 23 (11.6%) patients (odds ratio = 2.398, CI = 1.463–3.928, p = 0.001) compared to those with normal NT. Among the INT group, when the groups were subdivided into monochorionic (MC) and dichorionic (DC) pregnancies, 14.8% and 29.6% of the MC pregnancies had structural anomalies in one or both fetuses (odds ratio = 5.774, 95% CI = 1.445–23.071, p = 0.01) and twin-specific complications (odds ratio = 4.379, 95% CI = 1.641–11.684, p = 0.03), respectively, compared to DC pregnancies with 2.9% for structural anomalies and 8.8% for twin-specific complications. The prevalence of abnormal fetal karyotypes was not statistically different in patients with INT when compared between MC and DC pregnancies (p = 0.329). INT was associated with a higher rate of twin-specific complications and fetal structural anomalies in MC twin pregnancies rather than abnormal fetal karyotype. Therefore, NT measurement in MC twin pregnancies can be a useful tool for predicting adverse pregnancy outcomes. Appropriate counseling and surveillance based on the chorionicity are imperative in the prenatal care of twin pregnancies. MDPI 2021-01-23 /pmc/articles/PMC7865212/ /pubmed/33498637 http://dx.doi.org/10.3390/jcm10030433 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lee, SiWon
Lee, Hyun-Mi
Han, You Jung
Kim, Moon Young
Boo, Hye Yeon
Chung, Jin Hoon
Clinical Utility of Increased Nuchal Translucency at 11–13 Weeks of Gestation in Twin Pregnancies Based on the Chorionicity
title Clinical Utility of Increased Nuchal Translucency at 11–13 Weeks of Gestation in Twin Pregnancies Based on the Chorionicity
title_full Clinical Utility of Increased Nuchal Translucency at 11–13 Weeks of Gestation in Twin Pregnancies Based on the Chorionicity
title_fullStr Clinical Utility of Increased Nuchal Translucency at 11–13 Weeks of Gestation in Twin Pregnancies Based on the Chorionicity
title_full_unstemmed Clinical Utility of Increased Nuchal Translucency at 11–13 Weeks of Gestation in Twin Pregnancies Based on the Chorionicity
title_short Clinical Utility of Increased Nuchal Translucency at 11–13 Weeks of Gestation in Twin Pregnancies Based on the Chorionicity
title_sort clinical utility of increased nuchal translucency at 11–13 weeks of gestation in twin pregnancies based on the chorionicity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865212/
https://www.ncbi.nlm.nih.gov/pubmed/33498637
http://dx.doi.org/10.3390/jcm10030433
work_keys_str_mv AT leesiwon clinicalutilityofincreasednuchaltranslucencyat1113weeksofgestationintwinpregnanciesbasedonthechorionicity
AT leehyunmi clinicalutilityofincreasednuchaltranslucencyat1113weeksofgestationintwinpregnanciesbasedonthechorionicity
AT hanyoujung clinicalutilityofincreasednuchaltranslucencyat1113weeksofgestationintwinpregnanciesbasedonthechorionicity
AT kimmoonyoung clinicalutilityofincreasednuchaltranslucencyat1113weeksofgestationintwinpregnanciesbasedonthechorionicity
AT boohyeyeon clinicalutilityofincreasednuchaltranslucencyat1113weeksofgestationintwinpregnanciesbasedonthechorionicity
AT chungjinhoon clinicalutilityofincreasednuchaltranslucencyat1113weeksofgestationintwinpregnanciesbasedonthechorionicity